Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam with and without alcohol in healthy females
NCT04113343Phase 1Completed
- Sponsor
- PAION AG
- Start
- May 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of remimazolam (5 arms), sponsored by PAION AG. Primary endpoints: Paired Associates Learning Test, Modified Observer Assessment of Alertness/Sedation and 8 more. Started May 2017; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT04113343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113343.